Emobot
PrivateLast Round
Accelerator
Apr 16, 2025
Total Funding Raised
$200,000
Company Overview
Emobot operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was an Accelerator round in April 2025.
Emobot is a health technology company that provides a passive, multimodal AI monitoring platform for clinics to detect non-response and relapse in patients with mood disorders.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical AI, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emobot Comparables
Compare Emobot with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kintsugi | 78% | |
| Ellipsis Health | 76% | |
| Deliberate AI | 75% |
For institutional investors. Book with your work email.
Emobot Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 16, 2025 | ||||
| Grant | Oct 1, 2022 | ||||
| Grant | Feb 3, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Emobot Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iPEPS-ICM | Accelerator |
| OVHcloud Startup Program | Accelerator |
| Bpifrance | Grant, Accelerator |
| 21st by CentraleSupélec | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 2240% MoM, reaching 19.6K.
- Aug 22, 2025
Grew 20% QoQ from 15 to 18 employees.
For institutional investors. Book with your work email.
Emobot Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Emobot's valuation, stock price, and market status.
Is Emobot a public or private company?
Emobot is a private company.
What is the current stock price of Emobot?
Emobot is a private company, so its shares have no public market price. Caplight tracks Emobot's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emobot worth (valuation)?
Valuation information for Emobot is not publicly available.
Can I buy Emobot stock?
Emobot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emobot's last funding round?
Emobot's most recent funding round was Accelerator on April 16, 2025.
Who are the main investors in Emobot?
Key investors in Emobot include iPEPS-ICM, OVHcloud Startup Program, Bpifrance, 21st by CentraleSupélec.
Will Emobot IPO soon?
No public IPO plans have been announced for Emobot.
How can I track Emobot secondary market activity?
Caplight tracks bids, offers, and trades in Emobot's shares on secondary markets.